Kevin Weinfurt

I do work in patient-reported outcomes research, empirical bioethics, sexual medicine, and the art of giving scientific presentations.

[Kevin Weinfurt @KevinWeinfurt]

@stephensenn Sorry to say that I believe we (US) are responsible for 3 and 4.

[Kevin Weinfurt @KevinWeinfurt]

@stephensenn I highly recommend this book to all for its erudition and humor!

[JAMA @JAMA_current]

Kevin P. Weinfurt and Bryce B. Reeve discuss "Patient-Reported Outcome Measures in Clinical Research" with JAMA Statistical Editor Roger J. Lewis. Hosted on @amaedhub. https://t.co/SyK98Segyl

[Kevin Weinfurt @KevinWeinfurt]

@stephensenn It was an honor and a pleasure!

[ISOQOL @ISOQOL]

Join @4MelanieHawkins of @Swinburne, @RickSawatzky1 of @TrinityWestern, and @KevinWeinfurt of @DukeU for this webinar on 16 August.

Registration is still open! Details at https://t.co/ftvDobl5fs.

[Duke Research & Innovation @dukeresearch]

Learning to use freudenfreude on social media is helpful for young users, explains recent graduate Eleanor Robb. https://t.co/PnUpbvEmUd

[Kevin Weinfurt @KevinWeinfurt]

@jrboehnke @ISOQOL It was a joy doing that symposium with you as well @jrboehnke !

[Ana @ana_moga_mcgill]

#isoqol2022 I learnt a new language & paradigm for PROM Validation in the outstanding #ISOQOL workshop: Arguing for Validity structured EB validation practice to advance PRO measurement. Many thanks @4MelanieHawkins @Nancy2Mayo @_SandraNolte @KevinWeinfurt @RichardOsborne4 & Kara

[Duke Department of Population Health Sciences @duke_pophealth]

.@chvanhoutven writes in a @Health_Affairs essay, that although she is well-versed in how family caregivers can advocate for their patient, she had trouble navigating the system when her sister with intellectual disabilities was in the hospital. Read more https://t.co/i6jyPb7vUh

[Kevin Weinfurt @KevinWeinfurt]

FDA announced public webinar for PFDD draft Guidance 3 on clinical outcome assessments.
#COAs #clinicaltrials

https://t.co/ihm98tWFEW

[Kevin Weinfurt @KevinWeinfurt]

@chvanhoutven We missed you!

[Duke University School of Medicine @DukeMedSchool]

ICYMI: A @DukeCancer study published in February indicates that about one in seven breast cancers detected by mammography screening are over-diagnosed. Marc D. Ryser, PhD, Assistant Professor of Population Health Sciences and Duke Mathematics, explains. @duke_pophealth

[Kevin Weinfurt @KevinWeinfurt]

So excited to see this out to the public. Looking forward to all of the excellent input we’ll receive on this. #PatientReportedOutcomes #ClinicalTrials #measurement #ClinicalOutcomeAssessments

[FDA Drug Information @FDA_Drug_Info]

#FDA issues draft guidance on Patient-Focused Drug Development (#PFDD) to help sponsors identify or develop clinical outcome assessment measures of patients’ health that are appropriate for use in a medical product development program: https://t.co/Rwxu4BwteI

[NIH Pragmatic Trials Collaboratory @Collaboratory1]

Miss our May newsletter? Read more about our upcoming "critical questions" workshop on #pragmatictrials, a recent paper on ethics in machine learning, and a call for research in pediatric therapeutics. https://t.co/h2lJGL6Eqb

[Kevin Weinfurt @KevinWeinfurt]

Very well deserved!

[Duke Department of Population Health Sciences @duke_pophealth]

.@lmhcurtis receives the Excellence in Professionalism Award at this year's @DukeMedSchool Spring Faculty Celebration. Well deserved! Read more: https://t.co/5GXbh4RuRo

[Colin Begg @ColinBBegg]

Ever been concerned that the order of questions posed in a PRO affects the results? Paul Novotny et al. provide evidence that the ordering of domains does not affect the results. @SCTorg @MayoClinic @FDAOncology @EthanBasch1
https://t.co/fymZWuR8Rt

[Colin Begg @ColinBBegg]

How frequently should PROs be required in cancer trials to avoid under-reporting of symptoms? Every week, say Bellinda King-Kallimanis and colleagues. @bellkingkal @SCTorg @FDAOncology #PFDD @ethanbasch1 #clinicaltrials
https://t.co/WMY7hfF9dm

[Colin Begg @ColinBBegg]

Ethan Basch, Gita Thanarajasingham and Amylou Dueck outline a list of methodological standards for the use of PROs in cancer clinical trials. @SCTorg @ethanbasch1 @bellkingkal @FDAOncology #PFDD #clinicaltrials
https://t.co/E7HOUPLDYx

[Kevin Weinfurt @KevinWeinfurt]

Didn’t think I could respect and admire my friend @johnflint65 more than I already do. But this video increased that 10x. John’s courage and determination have saved countless lives and, with this video, are touching so many others.

https://t.co/RicmhVXqF7

[ISOQOL @ISOQOL]

Join us for this year's #MWMsymposium, which will kick off with presentations to bring light to theoretical models of HRQL in pediatrics, the challenges of measuring QOL and solutions to these challenges.

Learn more: https://t.co/uJcPP1NdgW

@ChildrensPhila @DukeMedSchool